当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.

Abstract：

:The expression of tumor-associated antigens (TAAs) might play a critical role in the control of minimal residual disease (MRD) in acute myeloid leukemia (AML), and therefore might be associated with clinical outcome in AML. In a DNA microarray analysis of 116 AML samples, we found a significant correlation between high mRNA levels of G250/CA9 and longer overall survival (P = .022), a similar trend with high mRNA levels of PRAME (P = .103), and a hint for RHAMM/HMMR. In contrast, for other TAAs like WT1, TERT, PRTN3, BCL2, and LAMR1, we found no correlation with clinical outcome. High expression of at least 1 of the 3 TAAs, RHAMM/HMMR, PRAME, or G250/CA9, provided the strongest favorable prognostic effect (P = .005). Specific T-cell responses were detected in 8 (47%) of 17 patients with AML in complete remission for RHAMM/HMMR-R3 peptide, in 7 (70%) of 10 for PRAME-P3 peptide, and in 6 (60%) of 10 for newly characterized G250/CA9-G2 peptide, a significant increased immune response compared with patients with AML patients who had refractory disease (P < .001). Furthermore, we could demonstrate specific lysis of T2 cells presenting these epitope peptides. In conclusion, expression of the TAAs RHAMM/HMMR, PRAME, and G250/CA9 can induce strong antileukemic immune responses, possibly enabling MRD control. Thus, these TAAs represent interesting targets for polyvalent immunotherapeutic approaches in AML.

journal_name

Blood

journal_title

Blood

authors

Greiner J,Schmitt M,Li L,Giannopoulos K,Bosch K,Schmitt A,Dohner K,Schlenk RF,Pollack JR,Dohner H,Bullinger L

doi

10.1182/blood-2006-01-023127

subject

Has Abstract

pub_date

2006-12-15 00:00:00

pages

4109-17

issue

13

eissn

0006-4971

issn

1528-0020

pii

blood-2006-01-023127

journal_volume

108

pub_type

临床试验,杂志文章

相关文献

BLOOD文献大全
  • Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).

    abstract：:In this cooperative study, we explored the role of the carbohydrate moiety (CHO) of von Willebrand factor (vWF) in supporting platelet adhesion. Because of previous discrepant results, all purification steps and CHO modifications by various enzymes were critically evaluated. Under our conditions, CHO-modified vWF prep...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Federici AB,De Romeuf C,De Groot PG,Samor B,Lombardi R,D'Alessio P,Mazurier C,Mannucci PM,Sixma JJ

    更新日期：1988-04-01 00:00:00

  • Hematopoietic stem-cell behavior in nonhuman primates.

    abstract：:Little is known about the behavior of hematopoietic stem cells (HSCs) in primates because direct observations and competitive-repopulation assays are not feasible. Therefore, we used 2 different and independent experimental strategies, the tracking of transgene expression after retroviral-mediated gene transfer (N = 1...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-02-075382

    authors： Shepherd BE,Kiem HP,Lansdorp PM,Dunbar CE,Aubert G,LaRochelle A,Seggewiss R,Guttorp P,Abkowitz JL

    更新日期：2007-09-15 00:00:00

  • Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes.

    abstract：:The turnover rates of beta and gamma globin messenger RNAs and of beta and gamma globin protein synthesis in human reticulocytes have been measured. Our goal was to determine whether beta globin mRNA is significantly more stable than gamma globin mRNA during the final stages of erythroid cell maturation. Such a result...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Ross J,Sullivan TD

    更新日期：1985-11-01 00:00:00

  • Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.

    abstract：:The transcription factor signal transducer and activator of transcription 5 (STAT5) fulfills essential roles in self-renewal in mouse and human hematopoietic stem cells (HSCs), and its persistent activation contributes to leukemic transformation, although little molecular insight into the underlying mechanisms has bee...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2010-08-303669

    authors： Fatrai S,Wierenga AT,Daenen SM,Vellenga E,Schuringa JJ

    更新日期：2011-03-24 00:00:00

  • Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.

    abstract：:Kaposi's sarcoma-associated herpes virus (KSHV)/human herpes virus 8 (HHV8) DNA sequences have been demonstrated in Kaposi's sarcoma (KS), as well as in some acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin's lymphomas (NHL) and in multicentric Castleman's disease. Although KSHV DNA generally is abundant ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Reed JA,Nador RG,Spaulding D,Tani Y,Cesarman E,Knowles DM

    更新日期：1998-05-15 00:00:00

  • Acute hyperviscosity: syndromes and management.

    abstract：:Plasma hyperviscosity is a rare complication of both monoclonal and polyclonal disorders associated with elevation of immunoglobulins. Asymptomatic patients with an elevation in the serum viscosity do not require plasma exchange, and the majority will have other indications for therapeutic intervention. For patients w...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2018-06-846816

    authors： Gertz MA

    更新日期：2018-09-27 00:00:00

  • A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

    abstract：:Human natural killer (NK) cells express Toll-like receptor 9 (TLR9) transcript and, upon exposure to microbial CpG oligodeoxynucleotide (ODN), release cytokines and kill target cells. Here we show that NK cell treatment with CpG ODN results in down-modulation of KIR3DL2 inhibitory receptor from the cell surface and in...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-12-256586

    authors： Sivori S,Falco M,Carlomagno S,Romeo E,Soldani C,Bensussan A,Viola A,Moretta L,Moretta A

    更新日期：2010-09-09 00:00:00

  • A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

    abstract：:We report results from a study exploring the combination of romidepsin, bortezomib, and dexamethasone for the treatment of patients with multiple myeloma (MM) previously treated with > 1 prior therapy. The primary objective was to determine the maximum tolerated dose (MTD) of the combination using a novel accelerated ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-03-339879

    authors： Harrison SJ,Quach H,Link E,Seymour JF,Ritchie DS,Ruell S,Dean J,Januszewicz H,Johnstone R,Neeson P,Dickinson M,Nichols J,Prince HM

    更新日期：2011-12-08 00:00:00

  • The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.

    abstract：:Myofibroblasts are fibrosis-driving cells and are well characterized in solid organ fibrosis, but their role and cellular origin in bone marrow fibrosis remains obscure. Recent work has demonstrated that Gli1+ and LepR+ mesenchymal stromal cells (MSCs) are progenitors of fibrosis-causing myofibroblasts in the bone mar...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2018-02-834820

    authors： Kramann R,Schneider RK

    更新日期：2018-05-10 00:00:00

  • Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.

    abstract：:Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disease arising from a hematopoietic stem cell expressing the BCR/ABL fusion protein. Leukemic and dendritic cells (DCs) develop from the same transformed hematopoietic progenitors. How BCR/ABL interferes with the immunoregulatory function of DCs in ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2008-05-156471

    authors： Mumprecht S,Claus C,Schürch C,Pavelic V,Matter MS,Ochsenbein AF

    更新日期：2009-05-07 00:00:00

  • A new human B-lymphocyte surface antigen (BL 2) detectable by a hybridoma monoclonal antibody: distribution on benign and malignant lymphoid cells.

    abstract：:A hybridoma-derived monoclonal antibody, produced by immunization with the Burkitt's tumor-derived B-lymphoblastoid cell line, B35M, was previously shown to detect a 68,000 dalton surface membrane protein, BL2, on the surface of peripheral blood B cells, which is absent from thymocytes, T cells, and granulocytes. In t...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Knowles DM 2nd,Tolidjian B,Marboe CC,Halper JP,Azzo W,Wang CY

    更新日期：1983-07-01 00:00:00

  • Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses.

    abstract：:The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cel...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-02-075945

    authors： Hipp MM,Hilf N,Walter S,Werth D,Brauer KM,Radsak MP,Weinschenk T,Singh-Jasuja H,Brossart P

    更新日期：2008-06-15 00:00:00

  • Multiple myeloma cell survival relies on high activity of protein kinase CK2.

    abstract：:Casein kinase 2 (CK2) is a ubiquitous cellular serine-threonine kinase that regulates relevant biologic processes, many of which are dysregulated in malignant plasma cells. Here we investigated its role in multiple myeloma (MM). Analysis of MM cell lines and highly purified malignant plasma cells in patients with MM r...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2005-11-013672

    authors： Piazza FA,Ruzzene M,Gurrieri C,Montini B,Bonanni L,Chioetto G,Di Maira G,Barbon F,Cabrelle A,Zambello R,Adami F,Trentin L,Pinna LA,Semenzato G

    更新日期：2006-09-01 00:00:00

  • CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines.

    abstract：:It has been reported that the activation of multiple myeloma (MM) cells by CD40 induces proliferation, growth arrest, and apoptosis. To determine whether the biologic sequelae of CD40 activation in MM cells depends on p53 function, we identified temperature-sensitive p53 mutations in the RPMI 8226 (tsp53E285K) and the...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Teoh G,Tai YT,Urashima M,Shirahama S,Matsuzaki M,Chauhan D,Treon SP,Raje N,Hideshima T,Shima Y,Anderson KC

    更新日期：2000-02-01 00:00:00

  • Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

    abstract：:Human natural killer (NK) cell development is a step-by-step process characterized by phenotypically identified stages. CD161 is a marker informative of the NK cell lineage commitment, whereas CD56, CD117, and CD94/NKG2A contribute to define discrete differentiation stages. In cells undergoing in vitro differentiation...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-09-379693

    authors： Montaldo E,Vitale C,Cottalasso F,Conte R,Glatzer T,Ambrosini P,Moretta L,Mingari MC

    更新日期：2012-04-26 00:00:00

  • The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines.

    abstract：:An immunosuppressant Rapamycin (Rap) has been reported to cause G1 arrest by inhibiting p70 S6 kinase and G1 cyclin/cdks kinase activities when added to quiescent cells with mitogens. However, antiproliferative effects of Rap on exponentially growing cells have been poorly investigated. We examined the intracellular e...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Kawamata S,Sakaida H,Hori T,Maeda M,Uchiyama T

    更新日期：1998-01-15 00:00:00

  • Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development.

    abstract：:To program pluripotent cells into blood, a knowledge of the locations of precursors during their journey through the embryo and the signals they experience would be informative. The anterior (a) and posterior (p) ventral blood islands (VBIs) in Xenopus are derived from opposite sides of the pregastrula embryo. The aVB...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-03-081323

    authors： Walmsley M,Cleaver D,Patient R

    更新日期：2008-02-01 00:00:00

  • Erratum: Airoldi I, Bertaina A, Prigione I, et al. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. Blood. 2015;125(15):2349-2358.

    abstract：:[This corrects the article DOI: 10.1182/blood-2014-09-599423.]. ...

    journal_title：Blood

    pub_type： 杂志文章,已发布勘误

    doi：10.1182/blood-2016-02-700625

    authors：

    更新日期：2016-03-24 00:00:00

  • Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes.

    abstract：:Macrophage colony-stimulating factor (M-CSF or CSF-1) and granulocyte-macrophage CSF (GM-CSF) have been shown to increase human monocyte urokinase-type plasminogen-activator (u-PA) activity with possible consequences for cell migration and tissue remodeling; because monocyte u-PA activity is likely to be controlled in...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Hamilton JA,Whitty GA,Stanton H,Wojta J,Gallichio M,McGrath K,Ianches G

    更新日期：1993-12-15 00:00:00

  • Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma.

    abstract：:We report a novel, reproducible methodology which enabled 10 human myeloma cell lines (HMCL) to be obtained from each of 10 tumor samples harvested from 9 patients with extramedullary proliferation. Fresh samples were cultured with interleukin 6 (IL-6) and granulocyte macrophage-colony stimulating factor (GM-CSF) at a...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Zhang XG,Gaillard JP,Robillard N,Lu ZY,Gu ZJ,Jourdan M,Boiron JM,Bataille R,Klein B

    更新日期：1994-06-15 00:00:00

  • How I diagnose and treat venous thromboembolism in sickle cell disease.

    abstract：:The incidence of venous thromboembolism (VTE) in adult patients with sickle cell disease (SCD) is high. However, overlapping features between the clinical presentation of VTE and SCD complications and a low index of suspicion for thrombosis can influence patient management decisions. VTE in SCD can therefore present m...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2018-03-822593

    authors： Shet AS,Wun T

    更新日期：2018-10-25 00:00:00

  • Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation.

    abstract：:During the course of differentiation of early human myeloid cells toward monocytes and granulocytes, cell surface expression of the cell adhesion molecule, CD11b/CD18 (Mo1) increases dramatically and expression of myeloperoxidase (MPO), a bacteriocidal enzyme, decreases markedly. Using the inducible promyelocytic cell...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Rosmarin AG,Weil SC,Rosner GL,Griffin JD,Arnaout MA,Tenen DG

    更新日期：1989-01-01 00:00:00

  • Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2.

    abstract：:Chemokines regulate hematopoiesis in part by influencing the proliferative status of myeloid progenitor cells (MPC). Human MCP-1/murine JE, a myelosuppressive chemokine, specifically binds C-C chemokine receptor 2 (CCR2). Transgenic mice containing a targeted disruption in CCR2 that prevents expression of CCR2 mRNA an...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Reid S,Ritchie A,Boring L,Gosling J,Cooper S,Hangoc G,Charo IF,Broxmeyer HE

    更新日期：1999-03-01 00:00:00

  • Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter.

    abstract：:Hemophilia B Leyden is an X chromosome-linked bleeding disorder characterized by an altered developmental expression of blood coagulation factor IX. This form of hemophilia B has been found to be associated with a variety of single point mutations in the factor IX promoter region. We now describe a novel point mutatio...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Reijnen MJ,Peerlinck K,Maasdam D,Bertina RM,Reitsma PH

    更新日期：1993-07-01 00:00:00

  • The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

    abstract：:The splenic marginal zone (MZ) is comprised of specialized populations of B cells, dendritic cells, and macrophages that are uniquely arrayed outside the white pulp follicles to screen the blood for bacterial and other particulate Ags. Mechanisms responsible for MZ B-cell formation, localization, retention, and functi...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-03-343608

    authors： Wang H,Beaty N,Chen S,Qi CF,Masiuk M,Shin DM,Morse HC 3rd

    更新日期：2012-01-12 00:00:00

  • Five years of experience with hydroxyurea in children and young adults with sickle cell disease.

    abstract：:The short-term beneficial effect of hydroxyurea (HU) in sickle cell disease (SCD) has been proven by randomized studies in children and adults. The Belgian registry of HU-treated SCD patients was created to evaluate its long-term efficacy and toxicity. The median follow-up of the 93 patients registered is 3.5 years; c...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.v97.11.3628

    authors： Ferster A,Tahriri P,Vermylen C,Sturbois G,Corazza F,Fondu P,Devalck C,Dresse MF,Feremans W,Hunninck K,Toppet M,Philippet P,Van Geet C,Sariban E

    更新日期：2001-06-01 00:00:00

  • Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis.

    abstract：:In 65 patients with hemophagocytic lymphohistiocytosis (HLH), we found an as yet undescribed heterogeneity of defects in cellular cytotoxicity when assay conditions were modified by the incubation time, the presence of mitogen, or interleukin-2 (IL-2). The standard 4-hour natural killer (NK) test against K562 targets ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2001-12-0260

    authors： Schneider EM,Lorenz I,Müller-Rosenberger M,Steinbach G,Kron M,Janka-Schaub GE

    更新日期：2002-10-15 00:00:00

  • HIV gene therapy research advances.

    abstract：:In this issue of Blood, Tebas et al report antiviral effects in a clinical trial of multiple infusions of lentiviral vector–modified autologous CD4T lymphocytes in 17 HIV-infected patients aviremic on antiretroviral therapy (ART). ...

    journal_title：Blood

    pub_type： 评论,杂志文章

    doi：10.1182/blood-2013-01-475921

    authors： Jacobson JM

    更新日期：2013-02-28 00:00:00

  • Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.

    abstract：:We used a sensitive real-time reverse transcription-polymerase chain reaction assay to quantify cyclin D1 mRNA levels in bone marrow samples collected at diagnosis from 74 newly diagnosed multiple myeloma (MM) patients who were randomized to undergo either single or double autologous peripheral blood stem cell transpl...

    journal_title：Blood

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1182/blood-2002-12-3789

    authors： Soverini S,Cavo M,Cellini C,Terragna C,Zamagni E,Ruggeri D,Testoni N,Tosi P,De Vivo A,Amabile M,Grafone T,Ottaviani E,Giannini B,Cangini D,Bonifazi F,Neri A,Fabris S,Tura S,Baccarani M,Martinelli G

    更新日期：2003-09-01 00:00:00

  • Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.

    abstract：:The inv(16)(p13q22) and t(16;16)(p13;q22) cytogenetic abnormalities occur commonly in acute myeloid leukemia (AML), typically associated with French-American-British (FAB) AML-M4Eo subtype. Reverse transcriptase-polymerase chain reaction (RT-PCR) techniques have been recently developed to detect the presence of severa...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Viswanatha DS,Chen I,Liu PP,Slovak ML,Rankin C,Head DR,Willman CL

    更新日期：1998-03-15 00:00:00